Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
50%
OVERLAP
BY WEIGHT
40
# OF OVERLAPPING
HOLDINGS
XBI
116
HOLDINGS
35%
ALSO IN BBP
BBP
65
HOLDINGS
66%
ALSO IN XBI
SECTOR DRIFT (XBI minus BBP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
INSMED INC | 3.3% | 3.3% | 3.3% |
|
ALNYLAM PHARMACEUTICALS INC | 3.5% | 3.0% | 3.0% |
|
HALOZYME THERAPEUTICS INC | 3.2% | 2.6% | 2.6% |
|
MADRIGAL PHARMACEUTICALS, INC. | 2.5% | 2.4% | 2.4% |
|
BRIDGEBIO PHARMA, INC. | 2.3% | 3.2% | 2.3% |
XBI Overweight Relative to BBP
|
ABBVIE INC | 2.5% |
|
NATERA INC | 2.2% |
|
EXACT SCIENCES CORP | 2.2% |
|
CYTOKINETICS INC | 2.0% |
|
REVOLUTION MEDICINES, INC. | 1.6% |
|
UNITED THERAPEUTICS CORP | 1.4% |
|
AVIDITY BIOSCIENCES INC | 1.3% |
|
VAXCYTE, INC. | 1.2% |
|
REGENERON PHARMACEUTICALS | 1.1% |
|
PROTAGONIST THERAPEUTICS, INC. | 1.1% |
XBI Underweight Relative to BBP
|
BEIGENE LTD. SPONSORED ADR | -2.9% |
|
INTRA-CELLULAR THERAPIES INC | -2.6% |
|
ASCENDIS PHARMA A/S | -2.6% |
|
PHATHOM PHARMACEUTICALS, INC. | -2.5% |
|
SAGE THERAPEUTICS INC | -2.5% |
|
LIGAND PHARMACEUTICALS-CL B | -2.4% |
 |
THERAVANCE BIOPHARMA INC | -2.3% |
|
MIRUM PHARMACEUTICALS, INC. | -2.3% |
|
BLUEPRINT MEDICINES CORP. | -2.3% |
|
AXSOME THERAPEUTICS, INC. | -2.2% |